Side-by-side financials for CLGN and SNN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CLGN | SNN |
|---|---|---|
| Market cap | - | $27.12 B |
| US-listed rank | - | #501 |
| Revenue (latest FY) | $2.37M | - |
| Net income (latest FY) | -$11.49M | - |
| Net margin | -484.6% | - |
| SEC filings | 317 | 2,390 |
Full pages: CollPlant Biotechnologies Ltd and SMITH & NEPHEW PLC, or browse the full rankings.